Determination of ceftazidime in plasma and cerebrospinal fluid by micellar electrokinetic chromatography with direct sample injection. 2005

Hsin-Hua Yeh, and Yuan-Han Yang, and Yu-Wei Chou, and Ju-Yun Ko, and Chia-An Chou, and Su-Hwei Chen
Graduate Institute of Pharmaceutical Sciences, Kaohsiung Medical University.

A simple micellar electrokinetic chromatography (MEKC) with UV detection at 254 nm for analysis of ceftazidime in plasma and in cerebrospinal fluid (CSF) by direct injection without any sample pretreatment is described. The separation of ceftazidime from biological matrix was performed at 25 degrees C using a background electrolyte consisting of Tris buffer with sodium dodecyl sulfate (SDS) as the electrolyte solution. Under optimal MEKC condition, good separation with high efficiency and short analyses time is achieved. Several parameters affecting the separation of the drug from biological matrix were studied, including pH and concentration of the Tris buffer and SDS. Using cefazolin as an internal standard (IS), the linear ranges of the method for the determination of ceftazidime in plasma and in CSF were all over the range of 3-90 microg/mL; the detection limit of the drug in plasma and in CSF (signal-to-noise ratio = 3; injection 0.5 psi, 5 s) was 2.0 microg/mL. The applicability of the proposed method for determination of ceftazidime in plasma and CSF collected after intravenous administration of 2 g ceftazidime in patients with meningitis was demonstrated.

UI MeSH Term Description Entries
D008297 Male Males
D008581 Meningitis Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6) Pachymeningitis,Meningitides,Pachymeningitides
D002021 Buffers A chemical system that functions to control the levels of specific ions in solution. When the level of hydrogen ion in solution is controlled the system is called a pH buffer. Buffer
D002442 Ceftazidime Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients. Ceftazidime Anhydrous,Ceftazidime Pentahydrate,Fortaz,Fortum,GR-20263,LY-139381,Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-,Tazidime,GR 20263,GR20263,LY 139381,LY139381
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013056 Spectrophotometry, Ultraviolet Determination of the spectra of ultraviolet absorption by specific molecules in gases or liquids, for example Cl2, SO2, NO2, CS2, ozone, mercury vapor, and various unsaturated compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Ultraviolet Spectrophotometry
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D020374 Chromatography, Micellar Electrokinetic Capillary A hybrid separation technique combining both chromatographic and electrophoretic separation principles. While the method was invented to separate neutral species, it can also be applied to charged molecules such as small peptides. MECC,MEKC,Micellar Electrokinetic Capillary Chromatography

Related Publications

Hsin-Hua Yeh, and Yuan-Han Yang, and Yu-Wei Chou, and Ju-Yun Ko, and Chia-An Chou, and Su-Hwei Chen
June 2004, Electrophoresis,
Hsin-Hua Yeh, and Yuan-Han Yang, and Yu-Wei Chou, and Ju-Yun Ko, and Chia-An Chou, and Su-Hwei Chen
August 1990, Journal of chromatography,
Hsin-Hua Yeh, and Yuan-Han Yang, and Yu-Wei Chou, and Ju-Yun Ko, and Chia-An Chou, and Su-Hwei Chen
October 2001, Clinica chimica acta; international journal of clinical chemistry,
Hsin-Hua Yeh, and Yuan-Han Yang, and Yu-Wei Chou, and Ju-Yun Ko, and Chia-An Chou, and Su-Hwei Chen
January 1997, Journal of capillary electrophoresis,
Hsin-Hua Yeh, and Yuan-Han Yang, and Yu-Wei Chou, and Ju-Yun Ko, and Chia-An Chou, and Su-Hwei Chen
February 1992, Journal of chromatography,
Hsin-Hua Yeh, and Yuan-Han Yang, and Yu-Wei Chou, and Ju-Yun Ko, and Chia-An Chou, and Su-Hwei Chen
June 1997, Journal of pharmaceutical and biomedical analysis,
Hsin-Hua Yeh, and Yuan-Han Yang, and Yu-Wei Chou, and Ju-Yun Ko, and Chia-An Chou, and Su-Hwei Chen
November 1992, Journal of chromatography,
Hsin-Hua Yeh, and Yuan-Han Yang, and Yu-Wei Chou, and Ju-Yun Ko, and Chia-An Chou, and Su-Hwei Chen
August 1993, Therapeutic drug monitoring,
Hsin-Hua Yeh, and Yuan-Han Yang, and Yu-Wei Chou, and Ju-Yun Ko, and Chia-An Chou, and Su-Hwei Chen
October 1994, Therapeutic drug monitoring,
Hsin-Hua Yeh, and Yuan-Han Yang, and Yu-Wei Chou, and Ju-Yun Ko, and Chia-An Chou, and Su-Hwei Chen
August 1998, Talanta,
Copied contents to your clipboard!